Search - tctmd.com

Displaying 161 - 180 of 421

Sort: Relevancy | Date

News Conference News TCT 2014

OCT STEMI: Imaging-Guided PCI Shows Promise

September 14, 2014

Presentation TCT 2014

The DCB-Only Approach Is Feasible: The Real Promise to Leave Nothing Behind!

Presenter: Franz X. Kleber

September 13, 2014

News Daily News

一项研究探讨了CLI患者腔内治疗后未愈合的预测因素

Caitlin E. Cox

September 02, 2014

News Daily News

Un Estudio Explora los Predictores de No Curación en Pacientes ICE Tras Tratamiento Endovascular

Caitlin E. Cox

September 02, 2014

News Daily News

Study Explores Predictors of Nonhealing in CLI Patients After Endovascular Therapy

Caitlin E. Cox

September 02, 2014

News Industry News

Sorin Group Announces First World Implant of CROWN PRT™ Heart Valve

September 02, 2014

News Daily News

Low Trial Participation Rate of MI Patients Raises Questions of Applicability

Todd Neale

September 02, 2014

News Daily News

研究发现，应当仅对风险最高的患者使用勒除器进行LAA封堵

Yael L. Maxwell

August 07, 2014

News Daily News

Study Indicates Snare Device for LAA Closure Should Only Be Used in Highest-Risk Patients

Yael L. Maxwell

August 07, 2014

News Daily News

Según Estudio un Dispositivo Cepo para el Cierre del AAI Solo debería de Usarse en los Pacientes de Más Alto Riesgo

Yael L. Maxwell

August 07, 2014

News Daily News

La Revascularización Híbrida Sigue Sin estar Disponible el Hospitales de EE.UU. Aunque están Probados sus Perfiles de Seguridad y Eficacia

L.A. McKeown

August 07, 2014

News Daily News

Hybrid Revascularization Still Not Widely Available in US Hospitals Even With Proven Efficacy, Safety

L.A. McKeown

August 07, 2014

News Daily News

联合血运重建有望给糖尿病患者带来福音

L.A. McKeown

July 24, 2014

News Industry News

Sorin Group Announces CE Mark Approval for CROWN PRT(TM) Heart Valve

July 24, 2014

News Daily News

Hybrid Revascularization a Promising Option for Diabetic Patients

L.A. McKeown

July 24, 2014

News Industry News

First patient enrollment in MASCOT registry represents major milestone for COMBO™ Dual Therapy Stent and OrbusNeich’s clinical program

July 16, 2014

News Industry News

Boston Scientific Receives CE Mark For Ranger™ Drug-Coated Balloon

July 14, 2014

News Daily News

Una Estrategia de Anticoagulación Potente con Reversión Rápida Post-PCI parece Segura y Efectiva

L.A. McKeown

July 03, 2014

News Daily News

Strategy of Potent Anticoagulation with Rapid Post-PCI Reversal Appears Safe, Effective

L.A. McKeown

July 03, 2014

News Industry News

Thoratec Announces First HeartMate III™ Human Implant And Start Of CE Mark Trial

June 27, 2014

Advertisement

OCT STEMI: Imaging-Guided PCI Shows Promise

The DCB-Only Approach Is Feasible: The Real Promise to Leave Nothing Behind!

一项研究探讨了CLI患者腔内治疗后未愈合的预测因素

Un Estudio Explora los Predictores de No Curación en Pacientes ICE Tras Tratamiento Endovascular

Study Explores Predictors of Nonhealing in CLI Patients After Endovascular Therapy

Sorin Group Announces First World Implant of CROWN PRT™ Heart Valve

Low Trial Participation Rate of MI Patients Raises Questions of Applicability

研究发现，应当仅对风险最高的患者使用勒除器进行LAA封堵

Study Indicates Snare Device for LAA Closure Should Only Be Used in Highest-Risk Patients

Según Estudio un Dispositivo Cepo para el Cierre del AAI Solo debería de Usarse en los Pacientes de Más Alto Riesgo

La Revascularización Híbrida Sigue Sin estar Disponible el Hospitales de EE.UU. Aunque están Probados sus Perfiles de Seguridad y Eficacia

Hybrid Revascularization Still Not Widely Available in US Hospitals Even With Proven Efficacy, Safety

联合血运重建有望给糖尿病患者带来福音

Sorin Group Announces CE Mark Approval for CROWN PRT(TM) Heart Valve

Hybrid Revascularization a Promising Option for Diabetic Patients

First patient enrollment in MASCOT registry represents major milestone for COMBO™ Dual Therapy Stent and OrbusNeich’s clinical program

Boston Scientific Receives CE Mark For Ranger™ Drug-Coated Balloon

Una Estrategia de Anticoagulación Potente con Reversión Rápida Post-PCI parece Segura y Efectiva

Strategy of Potent Anticoagulation with Rapid Post-PCI Reversal Appears Safe, Effective

Thoratec Announces First HeartMate III™ Human Implant And Start Of CE Mark Trial

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content